FDA says reviewing Acadia's Parkinson's medication, shares fall
WASHINGTON (Reuters) - The U.S. Food and Drug Administration said on Wednesday it was reviewing Acadia Pharmaceuticals' Parkinson's medication, the only approved drug used to treat hallucinations and delusions associated with the disease.
from Reuters: Health News https://reut.rs/2HsvglH
http://bit.ly/2zwRqiM